APTA vs. VAL, IXI, EVG, FAB, BSFA, ROQ, PYC, OCTP, NFX, and GENF
Should you be buying Aptamer Group stock or one of its competitors? The main competitors of Aptamer Group include ValiRx (VAL), IXICO (IXI), Evgen Pharma (EVG), Fusion Antibodies (FAB), BSF Enterprise (BSFA), Roquefort Therapeutics (ROQ), Physiomics (PYC), Oxford Cannabinoid Technologies (OCTP), Nuformix (NFX), and Genflow Biosciences (GENF). These companies are all part of the "biotechnology" industry.
Aptamer Group (LON:APTA) and ValiRx (LON:VAL) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, risk, dividends, media sentiment, valuation, institutional ownership, profitability, analyst recommendations and community ranking.
ValiRx received 150 more outperform votes than Aptamer Group when rated by MarketBeat users.
In the previous week, Aptamer Group's average media sentiment score of 0.00 equaled ValiRx'saverage media sentiment score.
Aptamer Group has a beta of -0.42, indicating that its share price is 142% less volatile than the S&P 500. Comparatively, ValiRx has a beta of 0.63, indicating that its share price is 37% less volatile than the S&P 500.
1.5% of Aptamer Group shares are owned by institutional investors. Comparatively, 0.1% of ValiRx shares are owned by institutional investors. 31.7% of Aptamer Group shares are owned by company insiders. Comparatively, 16.7% of ValiRx shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.
ValiRx's return on equity of -74.39% beat Aptamer Group's return on equity.
ValiRx has lower revenue, but higher earnings than Aptamer Group. ValiRx is trading at a lower price-to-earnings ratio than Aptamer Group, indicating that it is currently the more affordable of the two stocks.
Summary
Aptamer Group and ValiRx tied by winning 5 of the 10 factors compared between the two stocks.
Get Aptamer Group News Delivered to You Automatically
Sign up to receive the latest news and ratings for APTA and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding APTA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Aptamer Group Competitors List
Related Companies and Tools
